|
Autoimmune diseases
Citations 171-180 of 248 total displayed.
|
Past content
(since Jan 2001):
|
- EDITORIALS
Thalidomide neuropathy: Too much or too long?
- Stuart C. Apfel and Douglas W. Zochodne
Neurology 2004; 62: 2158-2159.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Thalidomide neurotoxicity: Prospective study in patients with lupus erythematosus
- C. Briani, G. Zara, R. Rondinone, S. Della Libera, M. Ermani, S. Ruggero, A. Ghirardello, S. Zampieri, and A. Doria
Neurology 2004; 62: 2288-2290.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Multiple sclerosis and occult gluten sensitivity
- Connie D.S.N.A. Pengiran Tengah, Robert J. Lock, D. Joseph Unsworth, and Adrian J. Wills
Neurology 2004; 62: 2326-2327.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Acute cerebellar ataxia due to Sjögren syndrome
- S. Wong, A. N. Pollock, J. M. Burnham, D. D. Sherry, and D. J. Dlugos
Neurology 2004; 62: 2332-2333.
[Full text]
[PDF]
- EDITORIALS
Is "seronegative" MG explained by autoantibodies to MuSK?
- Jon Lindstrom
Neurology 2004; 62: 1920-1921.
[Full text]
[PDF]
- EDITORIALS
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis
- Anthony T. Reder and Joel J. Oger
Neurology 2004; 62: 1922-1923.
[Full text]
[PDF]
- ARTICLES
Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration
- Y. Nishimoto, M. Koga, M. Kamijo, K. Hirata, and N. Yuki
Neurology 2004; 62: 1939-1944.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Are MuSK antibodies the primary cause of myasthenic symptoms?
- Duygu Selcen, Taku Fukuda, Xin-Ming Shen, and Andrew G. Engel
Neurology 2004; 62: 1945-1950.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neutralizing antibodies reduce the efficacy of ßIFN during treatment of multiple sclerosis
- S. Malucchi, A. Sala, F. Gilli, R. Bottero, A. Di Sapio, M. Capobianco, and A. Bertolotto
Neurology 2004; 62: 2031-2037.
[Abstract]
[Full text]
[PDF]
- NEUROIMAGES
Acute transverse myelitis in SLE
- Arun V. Krishnan and Gabor Michael Halmagyi
Neurology 2004; 62: 2087.
[Full text]
[PDF]
|
|
